NCT06430372View on ClinicalTrials.gov

Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2026

Conditions
Gastrointestinal CarcinomaDysplasiaGastrointestinal Polyp
Interventions
DRUG

Bev-ICG

Probe targeting VEGF-A that is topically administrated during the endoscopy

DEVICE

NIR-II fluorescence endoscopy platform

An endoscopic detection device which can detect and visualize NIR-II fluorescent signal during the endoscopy

Trial Locations (1)

100190

RECRUITING

Lidan Fu, Beijing

All Listed Sponsors
lead

Institute of Automation, Chinese Academy of Sciences

OTHER